| 영문 | simian virus | 한글 | 원숭이바이러스 |
|---|---|---|---|
| 설명 | 원숭이에서 분리된 바이러스. 아데노바이러스, 엔테로바이러스, 헤르페스바이러스 및 레오바이러스 등의 여러 군에 속한다. |
||
| 영문 | influenza virus | 한글 | 인플루엔자바이러스 |
|---|---|---|---|
| 설명 | 인플루엔자의 병원체. 상기도 점막에 침입하여 호흡기 질환을 일으킨다. 보체 결합 항원의 차이에 따라 A-B-C 세형태로 나뉘며, 유행할 때마다 혈구 응집 항원이 변이하여 광범위한 유행을 나타낸다. 껍질이 있는 80~150nm의 공모양, 나선 대칭 RNA 바이러스이다. 두 종류의 스파이크, 뉴라미니다아제(neuraminidase, NA), 당단백질과 헤마글루티닌(hemagglution, HA) 당단백질을 만든다. A형의 NA에는 N1-N2의 두 종류, HA에는 HAO-HA1-HA2-HA3의 네 종류가 있다. A형은 말-돼지-새에 감염하며 새로운 아형은 동물 바이러스와의 조환형이며, 그 밖에 동일 아형내 점변이가 있다. B, C형은 사람 이외에는 감염되지 않는다. 닭의 적혈구를 응집하는 성질이 있다. 바이러스 진단에는 환자의 인두 세척액에서 분리한다든가, 또는 환자의 혈청항체에 의한 특이적 적혈구 응집저지검사, 뉴라미니다아제 활성저지검사 또는 중화검사 등으로 검출한다. |
||
| PLV | partial liquid ventilation; poliomyelitis live vaccine; panleukopenia virus; phenylalanine, lysine, ... |
|---|---|
| RVV | right ventricular volume; rubella vaccine-like virus; Russell viper venom |
| TORCH | toxoplasmosis, other [congenital syphilis and viruses], rubella, cytomegalovirus, and herpes simplex... |
| HEV | health and environment; hemagglutinating encephalomyelitis virus; hepatitis E virus; hepato-encephal... |
| MUMPS | Massachusetts General Hospital Utility Multi-Programming System |
acute angle
| split-virus vaccine | <pharmacology> A vaccine composed of a purified antigenic determinant that is separated from the disease-causing organism. (06 Mar 1998) |
|---|---|
| vaccination, rubella | See Vaccination, MMR. (12 Dec 1998) |
| rubella | <disease, virology> An acute, usually benign, infectious disease caused by a togavirus and most often affecting children and nonimmune young adults, in which the virus enters the respiratory tract via droplet nuclei and spreads to the lymphatic system. It is characterised by a slight cold, sore throat and fever, followed by enlargement of the postauricular, suboccipital and cervical lymph nodes and the appearances of a fine pink rash that begins on the head and spreads to become generalised. Synonym: German measles, rubeola. Origin: L. Rubellus = reddish, ruber = red (17 Dec 1997) |
| rubella cataract | Embryopathic cataract secondary to intrauterine rubella infection. (05 Mar 2000) |
| rubella HI test | A haemagglutination inhibition (HI) test for rubella, often performed routinely as part of a prenatal workup of the pregnant woman; the presence of any detectable HI titre in the absence of disease indicates previous infection and immunity to reinfection; if HI antibody is undetected, the patient is considered potentially susceptible and is followed accordingly. See: haemagglutination inhibition. (05 Mar 2000) |
| rubella immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| rubella retinopathy | Peripheral pigmentary retinal changes in congenital rubella, not affecting visual function. (05 Mar 2000) |
| rubella syndrome, congenital | Transplacental infection of the foetus with rubella usually in the first trimester of pregnancy, as a consequence of maternal infection, resulting in various developmental abnormalities in the newborn infant. They include cardiac and ocular lesions, deafness, microcephaly, mental retardation, and generalised growth retardation. (12 Dec 1998) |
| congenital rubella syndrome | <syndrome> Foetal infection with rubella virus during the first trimester of pregnancy resulting in a series of congenital abnormalities including heart disease, deafness, and blindness. (05 Mar 2000) |
| immunization, rubella | See Immunization, MMR. (12 Dec 1998) |
| vaccination, mumps | See Vaccination, MMR. Vaccination, pneumococcal pneumonia: this vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
| metastatic mumps | Mumps complicated by involvement of organs other than parotid glands, such as the testis, breast, or pancreas. (05 Mar 2000) |
| mumps | An infectious acute viral disease affecting the parotid glands. The gonads, meninges and pancreas can also be affected. The causative agent is a paramyxovirus. Humans are the only natural host for this disease. Common symptoms include weakness, fever, sore throat, malaise and puffiness to the cheeks (due to parotid gland swelling). Patients are contagious 1 day prior to the onset of swelling until the swelling is gone. Recovery is generally in 2 weeks. (27 Sep 1997) |
| mumps immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| mumps in pregnancy | It has been stated, we believe erroneously, that mumps is dangerous when contracted during pregnancy. For example, vetter (infect med 14:730-733, 1997), citing a single 1980 article, writes: mumps infection during the first trimester of pregnancy can increase the rate of spontaneous abortion. Congenital anomalies associated with mumps infection during pregnancy include endocardial fibroelastosis; imperforate anus; spina bifida; and auditory, optic, and urogenital deformities. However, shepard in his authorative catalog of teratogenic agents (j hopkins u press, 8th edition, 1995) does not consider that mumps merits inclusion as a proven or even possible teratogenic agent, that is as an agent capable of causing a spontaneous abortion (a miscarriage) or causing congenital malformations (the baby is born with birth defects). Furthermore, mumps does not even warrant mention in smith's recognizable patterns of human malformation (by kl jones, wb saunders co., 5th edition, 1997), a key standard text on dysmorphology (the study of malformations). Based also on our review of the facts available at this time (oct, 1997), we conclude that there is insufficient evidence to label mumps as a particular hazard in pregnancy. (12 Dec 1998) |